Boston Scientific, Sprint among hedge fund favorites

Fri May 26, 2006



At the end of March, hedge funds had collectively built up concentrated positions in a select group of U.S. stocks, with Boston Scientific and Sprint Nextel emerging as favorites, according to new research by Goldman Sachs.

Goldman's analysis of recent filings with the U.S. Securities and Exchange Commission also found that at the end of the first quarter, hedge fund portfolios were tilted toward smaller companies and consumer discretionary stocks, while portfolios were "dramatically underweight" on financials...

TAKE A FREE TRIAL

The full contents of this article are available to active AR subscribers and trialists only.

To continue reading please,
take a free trialsubscribe or log in to AR.

Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now